These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 3102380)

  • 21. Assay of type-specific M antigens on whole group A streptococci.
    Miörner H; Larsson KN
    Eur J Clin Microbiol; 1984 Feb; 3(1):14-8. PubMed ID: 6368223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci.
    Wessels MR; Moses AE; Goldberg JB; DiCesare TJ
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8317-21. PubMed ID: 1656437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Streptococcal protective antigens (Spa): a new family of type-specific proteins of group A streptococci.
    Ahmed EA; Penfound TA; Brewer SC; Tennant PA; Chiang EY; Dale JB
    Eur J Clin Microbiol Infect Dis; 2010 Jan; 29(1):51-7. PubMed ID: 19865839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective and nonprotective epitopes from amino termini of M proteins from Australian aboriginal isolates and reference strains of group A streptococci.
    Brandt ER; Teh T; Relf WA; Hobb RI; Good MF
    Infect Immun; 2000 Dec; 68(12):6587-94. PubMed ID: 11083769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Common protective antigens of group A streptococcal M proteins masked by fibrinogen.
    Whitnack E; Dale JB; Beachey EH
    J Exp Med; 1984 Apr; 159(4):1201-12. PubMed ID: 6368736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective immunogenicity of group A streptococcal M-related proteins.
    Dale JB; Niedermeyer SE; Agbaosi T; Hysmith ND; Penfound TA; Hohn CM; Pullen M; Bright MI; Murrell DS; Shenep LE; Courtney HS
    Clin Vaccine Immunol; 2015 Mar; 22(3):344-50. PubMed ID: 25630406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Susceptibility of chicken embryos to group A streptococci: correlation with fibrinogen binding.
    Schmidt KH; Wiesner J; Gerlach D; Reichardt W; Ozegowski JH; Köhler W
    FEMS Immunol Med Microbiol; 1993 Oct; 7(3):231-40. PubMed ID: 8275054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strain-specific restriction of the antiphagocytic property of group A streptococcal M proteins.
    Kotarsky H; Thern A; Lindahl G; Sjöbring U
    Infect Immun; 2000 Jan; 68(1):107-12. PubMed ID: 10603375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunoglobulins inhibit adherence and internalization of Streptococcus pyogenes to human pharyngeal cells.
    Fluckiger U; Fischetti VA
    Adv Exp Med Biol; 1997; 418():909-11. PubMed ID: 9331796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of an Opsonophagocytic Killing Assay Using HL-60 Cells for Detection of Functional Antibodies against
    Salehi S; Hohn CM; Penfound TA; Dale JB
    mSphere; 2018 Dec; 3(6):. PubMed ID: 30567901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-phagocytic mechanisms of Streptococcus pyogenes: binding of fibrinogen to M-related protein.
    Courtney HS; Hasty DL; Dale JB
    Mol Microbiol; 2006 Feb; 59(3):936-47. PubMed ID: 16420362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced phagocytosis of group A streptococci M type 6 by oleic acid.
    Speert DP; Quie PG; Wannamaker LW
    J Infect Dis; 1981 Apr; 143(4):570-7. PubMed ID: 7017016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunochemical analysis in research on antibodies to Streptococcus group A ribosomes].
    Shikhman AR; Nikolaeva LV; Kondrakova OA; Savel'ev EP
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Feb; (2):73-6. PubMed ID: 3083622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Group A streptococcal antigens and vaccine potential.
    Kehoe MA
    Vaccine; 1991 Nov; 9(11):797-806. PubMed ID: 1722063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum opacity factor (SOF) of Streptococcus pyogenes evokes antibodies that opsonize homologous and heterologous SOF-positive serotypes of group A streptococci.
    Courtney HS; Hasty DL; Dale JB
    Infect Immun; 2003 Sep; 71(9):5097-103. PubMed ID: 12933852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression and immunogenicity of a streptococcal M protein epitope inserted in Salmonella flagellin.
    Newton SM; Kotb M; Poirier TP; Stocker BA; Beachey EH
    Infect Immun; 1991 Jun; 59(6):2158-65. PubMed ID: 2037377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bactericidal activity of M protein conserved region antibodies against group A streptococcal isolates from the Northern Thai population.
    Yoonim N; Olive C; Pruksachatkunakorn C; Pruksakorn S
    BMC Microbiol; 2006 Aug; 6():71. PubMed ID: 16895610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Localization of protective epitopes of the amino terminus of type 5 streptococcal M protein.
    Dale JB; Beachey EH
    J Exp Med; 1986 May; 163(5):1191-202. PubMed ID: 2422314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant tetravalent group A streptococcal M protein vaccine.
    Dale JB; Chiang EY; Lederer JW
    J Immunol; 1993 Aug; 151(4):2188-94. PubMed ID: 8345202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Restricted deposition of C3 on M+ group A streptococci: correlation with resistance to phagocytosis.
    Jacks-Weis J; Kim Y; Cleary PP
    J Immunol; 1982 Apr; 128(4):1897-902. PubMed ID: 7037956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.